These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect of immunization registry-based provider reminder to initiate HPV vaccination at age 9, Washington state. Christensen T; Zorn S; Bay K; Treend K; Averette C; Rhodes N Hum Vaccin Immunother; 2023 Dec; 19(3):2274723. PubMed ID: 37929936 [TBL] [Abstract][Full Text] [Related]
4. Adolescent Vaccination Performance in South Carolina Compared to the United States. Roberts JR; Naifeh M; Jacobson RM; Hinton E; O'Brien E; Rogacki B; Thompson D; Margolis B; Darden PM J S C Med Assoc; 2015 Dec-2016 Jan; 111(4):117-21. PubMed ID: 27141702 [TBL] [Abstract][Full Text] [Related]
5. Using the 4 Pillars™ Practice Transformation Program to increase adolescent human papillomavirus, meningococcal, tetanus-diphtheria-pertussis and influenza vaccination. Zimmerman RK; Raviotta JM; Nowalk MP; Moehling KK; Reis EC; Humiston SG; Lin CJ Vaccine; 2017 Oct; 35(45):6180-6186. PubMed ID: 28947346 [TBL] [Abstract][Full Text] [Related]
6. EDITORIAL. John JF J S C Med Assoc; 2015 Dec-2016 Jan; 111(4):114. PubMed ID: 27141700 [No Abstract] [Full Text] [Related]
7. Missed opportunities for adolescent vaccination, 2006-2011. Wong CA; Taylor JA; Wright JA; Opel DJ; Katzenellenbogen RA J Adolesc Health; 2013 Oct; 53(4):492-7. PubMed ID: 23809613 [TBL] [Abstract][Full Text] [Related]
8. MenACWY-TT is immunogenic when co-administered with Tdap and AS04-HPV16/18 in girls and young women: Results from a phase III randomized trial. Rivera L; Chanthavanich P; Põder A; Suryakiran PV; Jastorff A; Van der Wielen M Vaccine; 2018 Jun; 36(27):3967-3975. PubMed ID: 29789243 [TBL] [Abstract][Full Text] [Related]
9. Patterns of Use of Human Papillomavirus and Other Adolescent Vaccines in the United States. Vielot NA; Butler AM; Brookhart MA; Becker-Dreps S; Smith JS J Adolesc Health; 2017 Sep; 61(3):281-287. PubMed ID: 28739327 [TBL] [Abstract][Full Text] [Related]
10. Collaborative patient-provider communication and uptake of adolescent vaccines. Moss JL; Reiter PL; Rimer BK; Brewer NT Soc Sci Med; 2016 Jun; 159():100-7. PubMed ID: 27176467 [TBL] [Abstract][Full Text] [Related]
11. Missed Opportunities for Human Papillomavirus Vaccine Initiation in an Insured Adolescent Female Population. Espinosa CM; Marshall GS; Woods CR; Ma Q; Ems D; Nsiah I; Happe LE; Smith MJ J Pediatric Infect Dis Soc; 2017 Nov; 6(4):360-365. PubMed ID: 29036336 [TBL] [Abstract][Full Text] [Related]
12. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). Broder KR; Cortese MM; Iskander JK; Kretsinger K; Slade BA; Brown KH; Mijalski CM; Tiwari T; Weston EJ; Cohn AC; Srivastava PU; Moran JS; Schwartz B; Murphy TV; MMWR Recomm Rep; 2006 Mar; 55(RR-3):1-34. PubMed ID: 16557217 [TBL] [Abstract][Full Text] [Related]
13. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. America Academy of Pediatrics Commitee on Infectious Diseases Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131 [TBL] [Abstract][Full Text] [Related]
14. Early Outcomes of a Multilevel Human Papillomavirus Vaccination Pilot Intervention in Federally Qualified Health Centers. Fisher-Borne M; Preiss AJ; Black M; Roberts K; Saslow D Acad Pediatr; 2018 Mar; 18(2S):S79-S84. PubMed ID: 29502642 [TBL] [Abstract][Full Text] [Related]
15. The preteen visit: an opportunity for prevention. Campos-Outcalt D J Fam Pract; 2006 Dec; 55(12):1054-6. PubMed ID: 17137541 [TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and safety of the quadrivalent meningococcal vaccine MenACWY-TT co-administered with a combined diphtheria-tetanus-acellular pertussis vaccine versus their separate administration in adolescents and young adults: A phase III, randomized study. Rivera L; Schwarz TF; Kim KH; Kim YK; Behre U; Cha SH; Jo DS; Lee J; Lee JS; Cheuvart B; Jastorff A; Van der Wielen M Vaccine; 2018 Jul; 36(31):4750-4758. PubMed ID: 29960800 [TBL] [Abstract][Full Text] [Related]
17. Middle school vaccination requirements and adolescent vaccination coverage. Bugenske E; Stokley S; Kennedy A; Dorell C Pediatrics; 2012 Jun; 129(6):1056-63. PubMed ID: 22566425 [TBL] [Abstract][Full Text] [Related]
18. Physician clinical decision support system prompts and administration of subsequent doses of HPV vaccine: A randomized clinical trial. Wilkinson TA; Dixon BE; Xiao S; Tu W; Lindsay B; Sheley M; Dugan T; Church A; Downs SM; Zimet G Vaccine; 2019 Jul; 37(31):4414-4418. PubMed ID: 31201057 [TBL] [Abstract][Full Text] [Related]
19. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2017. Walker TY; Elam-Evans LD; Yankey D; Markowitz LE; Williams CL; Mbaeyi SA; Fredua B; Stokley S MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(33):909-917. PubMed ID: 30138305 [TBL] [Abstract][Full Text] [Related]
20. Update on Adolescent Immunizations. Schreier R; Halady T; Bishop N; Chatterjee A S D Med; 2016 Feb; 69(2):78-83. PubMed ID: 26999915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]